Other
Immunotherapy

MGRC’s cancer treatment options are not limited to just CAR T-Cell Immunotherapy. We also offer alternative immunotherapies that may be more suited for the patient’s cancer prognosis.

Available Other
Immunotherapy Products

https://immunotherapy.life/wp-content/uploads/2021/02/Diagram-Other-Immunotheraphy.png
IMMUNOTHERAPY GENE PRODUCT TYPE OF CANCER
Tumour-Associated Antigen T-Cell (TAA-T) Therapy
  • Pancreatic
  • Neuroblastoma
  • Melanoma
  • Wilms Tumour
  • Sarcomas
T-Cell Receptor T-Cell (TCR-T) Therapy
  • HPV-associated cancers, including cervical cancer
Tumour-Infiltrating Lymphocyte (TIL) Therapy,
Short Chain Variable Fragment Immune Checkpoint
Inhibitors (scFv ICI)-PD-1, CD47
  • Various Advanced Cancers

THE DIFFERENCE

Chemotherapy
VS Immunotherapy

While chemotherapy and immunotherapy both aim to rid the human body of cancerous cells, the way two treatments work differ vastly. We’ve laid out the differences to encourage informed decisions for everyone.

https://immunotherapy.life/wp-content/uploads/2021/02/iStock-944834546.png
https://immunotherapy.life/wp-content/uploads/2021/02/iStock-944834546.png

Interested In Learning More About
Our Other Immunotherapy Treatments?
Reach Out To Us And We’ll Get In Touch

COMPANY

Sign up for you and your loved ones to receive the latest news and updates about other immunotherapies.

    https://immunotherapy.life/wp-content/uploads/2021/02/MGRC-LogoFooter.png
    https://immunotherapy.life/wp-content/uploads/2021/01/MGRC-Logo.png
    https://immunotherapy.life/wp-content/uploads/2021/01/MGRC-Logo.png
    https://immunotherapy.life/wp-content/uploads/2021/01/MGRC-Logo.png

    Copyright © 2021 Malaysian Genomics Resource Centre Berhad (652790-V). All Rights Reserved.

    Copyright © 2021 Malaysian Genomics Resource Centre Berhad (652790-V). All Rights Reserved.